NIH-funded research NIH-funded research

Identifying key immune targets for vaccines against insect-borne viruses

Official title: Functional B-cell Epitope Discovery for Arthropod-Borne Diseases

Funded at Washington University · NIH-11196675 · Data updated 2026-11-12

This study is looking at parts of viruses that help our immune system fight them off, especially focusing on how certain pieces can spark strong responses from protective antibodies, with the hope of creating better vaccines and treatments for diseases spread by bugs.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 16, 2024
Project endSeptember 15, 2025
Funding year2024
Award (this year)$1,794,234
NIH project number75N93024C00070-0-9999-1
Project IDNIH-11196675 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would be individuals at risk of infections from arthropod-borne viruses, such as those living in endemic areas.

Less likely to help

Patients who are not at risk for arthropod-borne diseases or those who have already been vaccinated against these viruses may not benefit from this research.

What this research studies

This research aims to identify specific parts of viruses that trigger strong immune responses, particularly focusing on B cell epitopes recognized by protective antibodies. By studying these immune responses in mouse models, the researchers hope to establish connections between these viral components and the effectiveness of neutralizing antibodies. The ultimate goal is to pave the way for developing safe and effective vaccines and treatments for diseases caused by arthropod-borne viruses.

Why it matters

Potential benefit: If successful, this research could lead to the development of new vaccines and therapies that protect against serious infections from insect-borne viruses.

How similar studies have gone: Previous research has shown promise in identifying immune targets for vaccine development against similar viral infections, indicating a potential for success in this approach.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.